Acceleron Pharma Inc Current ratio
Mi az Acceleron Pharma Inc Current ratio?
A Current ratio az Acceleron Pharma Inc - 12.14
Mi a Current ratio meghatározása?
A jelenlegi arány likviditási mutató, amely azt méri, hogy a vállalatnak elegendő forrása van-e a rövid távú kötelezettségek teljesítéséhez.
The current ratio is an indication of a company's liquidity and measures the capability to meet a company's short-term obligations. It compares a firm's current assets to its current liabilities, and is expressed as current assets divided by current liabilities. The ratio is only useful when two companies are compared within industry because inter industry business operations differ substantially. To determine liquidity, the current ratio is not as helpful as the quick ratio, because it includes all those assets that may not be easily liquidated, like prepaid expenses and inventory.
Acceptable current ratios vary from industry to industry. In many cases an investor would consider a high current ratio to be better than a low current ratio, because a high current ratio indicates that the company is more likely to pay the investor back. Large current ratios are not always a good sign for investors. If the company's current ratio is too high it may indicate that the company is not efficiently using its current assets or its short-term financing facilities. If current liabilities exceed current assets the current ratio will be less than 1. A current ratio of less than 1 indicates that the company may have problems meeting its short-term obligations.
Some types of businesses can operate with a current ratio of less than one however. If inventory turns into cash much more rapidly than the accounts payable become due, then the firm's current ratio can comfortably remain less than one. Inventory is valued at the cost of acquiring it and the firm intends to sell the inventory for more than this cost. The sale will therefore generate substantially more cash than the value of inventory on the balance sheet. Low current ratios can also be justified for businesses that can collect cash from customers long before they need to pay their suppliers.
Current ratio a Health Care szektor a NASDAQ-on cégekben a Acceleron Pharma Inc -hoz képest
Mit csinál Acceleron Pharma Inc?
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
current ratio -hoz hasonló cégek Acceleron Pharma Inc
- Alfred Herbert (India) nak Current ratio 12.10 van
- Unicorn AIM VCT plc nak Current ratio 12.10 van
- MRG Metals Ltd nak Current ratio 12.11 van
- Color Star Technology Co nak Current ratio 12.12 van
- Medallion nak Current ratio 12.13 van
- National Western Life Inc nak Current ratio 12.13 van
- Acceleron Pharma Inc nak Current ratio 12.14 van
- Metacrine nak Current ratio 12.15 van
- Kingfisher Mining nak Current ratio 12.16 van
- Bellus Health Inc nak Current ratio 12.16 van
- Orasure Technologies nak Current ratio 12.17 van
- Akcea Therapeutics Inc nak Current ratio 12.17 van
- AMREP nak Current ratio 12.19 van